Phase 2 study of Wee1 inhibitor adavosertib in recurrent uterine carcinosarcoma.
Cham S, Xiong N, Tayob N, Krasner C, Wright AA, Lee EK, Sawyer H, Mathews C, Konstantinopoulos PA, Matulonis UA, Liu JF.
Cham S, et al.
Gynecol Oncol Rep. 2025 Jun 24;60:101796. doi: 10.1016/j.gore.2025.101796. eCollection 2025 Aug.
Gynecol Oncol Rep. 2025.
PMID: 40678577
Free PMC article.